SOURCE: PetVivo Holdings, Inc.

PetVivo Holdings, Inc. Featured in Minneapolis / St. Paul Business Journal Article

PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics is featured in an article titled "Med-tech-for-pets venture in deal to buy Gel-Del for at least $40M" in the Minneapolis / St. Paul Business Journal. Reporter Katharine Grayson interviewed PetVivo CEO John Lai regarding the recently announced signing of a binding term sheet for a merger with Gel-Del Technologies, Inc.

 

The article can be found at the following link: http://www.bizjournals.com/twincities/blog/in_private/2014/06/medtech-pets-venture-in-deal-to-buy-gel-del-for.html

 

Under the agreed upon terms Gel-Del will merge with PetVivo Holdings, Inc. and upon resolution of certain conditions specified as terms, a definitive agreement will consummate the merger. Details of the merger have been filed by PetVivo Holdings with the Securities and Exchange Commission and can be found on Edgar.

 

About PetVivo Holdings, Inc.: PetVivo, Inc. is a wholly owned subsidiary of PetVivo Holdings, Inc. (OTCQB: PETV) based in Minneapolis, Minnesota. PetVivo is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and other therapeutics for pets.

 

PetVivo, Inc. believes that it can leverage the investments in the human bio-materials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated veterinary pharmaceuticals or human therapeutics.

 

The foregoing material may contain forward-looking statements. We caution that such statements may be subject to uncertainties and that actual results could differ materially from the forward-looking statements. Readers accordingly should not place undue reliance on these forward-looking statements, which do not reflect unknown or unanticipated events or circumstances occurring after the date of these forward-looking statements.

 

 

CONTACT: 

 

PetVivo: 

John Lai 

Chief Executive Officer 

PetVivo Holdings, Inc. 

Email: info@petvivo.com 

Phone: 612-296-7305

 

 

SOURCE: PetVivo Holdings, Inc.